In Brief
Megaplexes containing a GPCR simultaneously engaged with a G protein and b-arrestin sustain G protein signaling following internalization into endosomes.
INTRODUCTION
G protein-coupled receptor (GPCR) signaling ensues when an agonist binds to and stabilizes an active receptor conformation. This agonist bound GPCR, acting through its transmembrane core, promotes interaction with heterotrimeric G proteins (Gabg), thus stimulating guanine nucleotide exchange and separation of the Ga subunit from the Gbg subunits (Gilman, 1987) . G protein subunits then interact with a variety of effectors, such as enzymes and ion channels, to initiate downstream responses (Gilman, 1987; Pierce et al., 2002) .
To terminate G protein signaling, cells have devised a specialized desensitization mechanism that includes phosphorylation of receptors by GPCR kinases (GRKs) and subsequent recruitment of b-arrestins (barrs) to the phosphorylated receptor (Moore et al., 2007) . barrs engage both the phosphorylated C-tail and the transmembrane core of the receptor. The latter interaction overlaps with the G protein-binding site and thus sterically hinders further G protein activation (Kang et al., 2015; Shukla et al., 2014; Szczepek et al., 2014) . Additionally, barr binding initiates receptor internalization by interaction with the endocytic machinery (i.e., clathrin, adaptin-2, etc.) (Goodman et al., 1996; Laporte et al., 1999) . Depending on the strength of the GPCR-barr interaction, the receptor may either undergo transient internalization, followed by recycling to the plasma membrane for weak interactions (class A GPCRs), or sustained internalization into endosomes for stronger interactions (class B GPCRs) (Oakley et al., , 2000 . Furthermore, barrs themselve serve as an alternative signaling system by acting as adaptors and scaffolds to interact with numerous signaling molecules (Pierce et al., 2002) . Thus, our current understanding features G protein signaling originating at the cell surface, followed by rapid barr-mediated quenching of G protein signaling, both by competition with G proteins for receptor interaction and by internalization of the receptors. However, recent findings have begun to challenge these paradigms. A number of GPCRs have been reported to engage in sustained G protein signaling, rather than being desensitized after initial agonist stimulation (Calebiro et al., 2009; Feinstein et al., 2013; Ferrandon et al., 2009; Irannejad et al., 2013; Mullershausen et al., 2009) . Interestingly, this newly appreciated sustained phase of G protein activation appears to be mediated by internalized receptors in endosomes, where they modulate effectors, such as adenylyl cyclase (Calebiro et al., 2009; Feinstein et al., 2011 Feinstein et al., , 2013 Ferrandon et al., 2009; Irannejad et al., 2013; Mullershausen et al., 2009 ). These findings cannot be accommodated within the traditional model of GPCR signaling systems since prolonged residence of a GPCR in endosomes requires a persistent ''class B'' interaction of barr with the receptors, which should prevent G protein activation (Feinstein et al., 2011 Wehbi et al., 2013) .
Recent X-ray crystallographic findings of the b 2 -adrenergic receptor (b 2 AR) in complex with Gs have indicated that the receptor forms a highly engaged complex with Gs that involves interactions of both the N-terminal and C-terminal domains of the Gas subunit with intracellular loop 2, transmembrane domain 5 (TM5), and TM6 of the b 2 AR . A negative-stain electron microscopy (EM) study of GPCR-barr complexes using a b 2 V 2 R receptor chimera (b 2 AR where the C-terminal tail was exchanged for the vasopressin type 2 receptor [V 2 R] C-terminal) revealed that barr assumes two different conformations (Shukla et al., 2014) ; one in which the barr is bound only to the phosphorylated receptor C-terminal tail and appears to hang from the receptor (''tail'' conformation) and a second more fully engaged conformation, in which, in addition to the tail interaction, a flexible loop in barr, termed the fingerloop, inserts into the transmembrane core of the receptor (''core'' conformation). An arrangement similar to this ''core'' conformation was recently described in a crystal structure of a rhodopsinvisual arrestin complex (Kang et al., 2015) .
The observation of the ''tail'' conformation of the GPCR-barr complex, in which the entire receptor cytoplasmic surface encompassing intracellular loops 1, 2, and 3 is exposed, raises the question of whether it might be possible for both Gs and barr to simultaneously interact with the receptor and thus provide a molecular basis for sustained G protein signaling by GPCRs from endosomes. Accordingly, here we set out to test this hypothesis by using a variety of cellular, biochemical, and biophysical approaches.
RESULTS
Real-Time Cyclic AMP Kinetic Studies of Class A and Class B GPCRs Sustained G protein signaling by internalized GPCRs has been demonstrated for a number of receptors. Interestingly, this feature has been more commonly observed in class B GPCRs, including the parathyroid hormone type 1 receptor (PTHR) (Ferrandon et al., 2009) , V 2 R , and thyroid-stimulating hormone receptor (TSHR) (Calebiro et al., 2009 ). These receptors form more stable complexes with barr compared to class A GPCRs, which only transiently interact with barr (Oakley et al., 2000) . Given that class B receptors bind barr more tightly, and given the well-characterized role of barr in desensitizing GPCRs, it seems paradoxical that class B receptors, rather than class A receptors, promote sustained G protein signaling.
To directly assess the relative propensity of class A and B GPCRs to promote sustained signaling, we monitored agoniststimulated Gs signaling, measured here as cyclic AMP (cAMP) accumulation, in HEK293 cells stably expressing ICUE2, a fluorescence resonance energy transfer (FRET) biosensor detecting cytoplasmic cAMP (Violin et al., 2008) . This ICUE2 biosensor measures cAMP concentration in real-time and thus represents an equilibrium between production and degradation of cAMP. These cells were transiently transfected with the b 2 AR as a prototypical class A GPCR or the V 2 R as a prototypical class B GPCR. In addition, we used a modified version of the b 2 AR, the b 2 V 2 R, in which the b 2 AR C-terminal tail has been exchanged with the V 2 R C-terminal tail. The b 2 V 2 R maintains the pharmacological properties of the b 2 AR, but has significantly higher affinity for barr than for b 2 AR, and this increase in affinity manifests predominantly as a change in the receptor internalization pattern from class A to B (Oakley et al., , 2000 . In addition, we have successfully purified stable and functional GPCR-barr complexes using the b 2 V 2 R. Therefore, the b 2 V 2 R was used to study both the cellular and biophysical basis for sustained G protein signaling by internalized class B GPCR-barr complexes.
Within the first 5 min of agonist challenge b 2 AR, b 2 V 2 R, and V 2 R all stimulated cAMP production to a similar extent. Beyond 5 min, the cAMP responses were attenuated to different levels among these receptors and most prominently for the wild-type b 2 AR ( Figure 1A ). In addition, the agonist-stimulated cAMP response was diminished slightly more at the b 2 V 2 R compared to the V 2 R ( Figure 1A ). These results suggest that class B GPCRs promote sustained G protein signaling to a greater degree than does a prototypical class A GPCR.
To investigate whether sustained G protein signaling of class B GPCRs arises from internalized compartments b 2 AR, b 2 V 2 R, or V 2 R-expressing cells were agonist-stimulated for 10 min to allow for internalization to occur. Then Gs signaling arising from only the cell membrane was inhibited by the addition of 10 mM of a membrane-impermeable antagonist ( Figure 1B ) (Jard et al., 1986; Staehelin et al., 1983) . To inhibit Gs signaling arising from both the cell membrane and the internalized compartments, 10 mM of a cell-permeable antagonist (ICI-118551 for b 2 AR and b 2 V 2 R or SR121463 for V 2 R; Figure 1B ) was used (Morello et al., 2000; O'Donnell and Wanstall, 1980) . Under these conditions, for the b 2 AR, both antagonists quickly inhibited almost all Gs signaling ( Figure 1C ). However, for the b 2 V 2 R, only ICI-118551 fully blocked Gs signaling, whereas CGP-12177 only partially inhibited it ( Figure 1C ). These results indicate that a significant fraction of the b 2 V 2 R-stimulated cAMP originates from internalized compartments. In a similar fashion, the V 2 R-stimulated cAMP response was only partially antagonized when exposed to the cell-membrane-impermeable antagonist, H-3192, but fully antagonized following the addition of the cell-membrane-permeable antagonist, SR121463 (Figure 1C) . Therefore, V 2 R-mediated Gs signaling at 10 min postagonist-stimulation is, in part, due to internalized receptors. These results demonstrate that both the b 2 V 2 R and V 2 R stimulate Gs signaling from internalized compartments, whereas the b 2 AR does not seem to exhibit such behavior using this method.
Monitoring Heterotrimeric Gs Activation at Internalized
Compartments by Class A and Class B GPCRs Using Bioluminescence Resonance Energy Transfer Biosensors To confirm that the receptor-stimulated cAMP response from internalized compartments results from Gs activation, and not from other signaling cascades, we directly monitored agonist-stimulated heterotrimeric Gs activation by bioluminescence resonance energy transfer (BRET), which detects the proximity between two proteins within a 10 nm range (Marullo and Bouvier, 2007) . Following Gs activation, the Gas subunit separates from the Gbg subunits. This separation was detected following agonist challenge of b 2 AR, b 2 V 2 R, or V 2 R-expressing cells as a decrease in BRET between the functionally validated BRET pair RlucII-117-Gas and GFP10-Gg1 (Figures 2A, 2B , and S1). Such BRET-based assays have been developed as sensors of G protein activation (Galé s et al., 2006) .
To specifically monitor Gs activation/separation at internalized compartments, we developed an agonist washout protocol. In short, agonists were allowed to stimulate receptors for varying time intervals (0.5 to 14 min), followed by a washout of the agonists. Next, the cells were incubated for 20 min in agonist-free media, and responses were recorded ( Figures 1B and 2C ). Since washout only removes agonist from the extracellular environment, but not from the intracellular environment, which contains internalized receptors, the receptors insensitive to agonist washout must be activating the Gs from within internalized compartments ( Figure 1B) .
As shown in Figure 2C , the agonist washout protocol blunted Gs activation in b 2 AR, b 2 V 2 R, and V 2 R-expressing cells. However, by increasing the duration of stimulation prior to agonist washout, and thereby allowing more receptors to internalize, a substantially diminished signal reduction by agonist washout was observed ( Figure 2C ). This dampening in signal reduction was most prominent, and statistically significant, for b 2 V 2 R and V 2 R, which still maintained 54% and 64% of their Gs activity, respectively, when cells were pre-stimulated for 14 min followed by agonist washout, as compared to the unwashed control conditions ( Figure 2C ). For the b 2 AR, increasing the duration of stimulation prior to agonist washout did not result in a statistically . The impact of cell-membrane-impermeable antagonists was measured relative to total antagonism caused by cell-membrane-permeable antagonists (ICI-118551 for b 2 AR and b 2 V 2 R or SR121463 for V 2 R). Data represent the mean ± SE of N = 3 experiments and n R 87 cells. AUC was used to calculate the total cAMP response for each GPCR after the respective treatments. One-way ANOVA was performed to determine statistical differences among the antagonists compared to DMSO (*p < 0.05; ***p < 0.001; ****p < 0.0001) or compared to cell-membrane-impermeable antagonists (#, p < 0.05; ####, p < 0.0001). See also Figure S1 .
significant difference in remaining Gs activity when compared to 0.5 min pulse stimulation ( Figure 2C ). In this setup, the class B GPCRs, b 2 V 2 R and V 2 R, seem to activate heterotrimeric Gs from internalized compartments, whereas the class A GPCR, b 2 AR, does not to any significant degree.
Co-localization of GPCR, barr, and Gas in Endosomes by Confocal Microscopy
Receptor internalization from the plasma membrane into endosomes is driven by formation of a GPCR-barr complex. Therefore, to investigate whether G protein may interact with GPCR-barr complexes in endosomes, we began by tracking the cellular localization of functionally validated N-terminal SNAP-tagged GPCRs (SNAP-b 2 AR, SNAP-b 2 V 2 R, or SNAP-V 2 R) pre-labeled with SNAP-Surface 649 fluorescence substrate, mStrawberry-barr2, and mEmerald-67-Gas expressed in HEK293 cells following agonist treatment using confocal microscopy ( Figure S1 ). Prior to agonist stimulation, SNAP-tagged receptors (b 2 AR, b 2 V 2 R, or V 2 R) and mEmerald-67-Gas were predominantly located at the plasma membrane, whereas mStrawberrybarr2 was evenly distributed throughout the cytoplasm ( Figures  3A, S2 , and S3A). Following agonist stimulation, mEmerald-67-Gas rapidly translocates from the plasma membrane to (A) Schematic representation of the experimental design used to monitor agonist-promoted Gs activation, which leads to the separation of Gas and Gbg subunits, measured by BRET between RlucII-117-Gas and GFP10-Gg1. (B) BRET titration curves obtained using a constant amount of RlucII-Gas and with increasing amounts of GFP10-Gg1. BRET was measured 35 min following the addition of agonist or vehicle. Data are pooled from N = 4 experiments. (C) Relationship between the duration of agonist stimulation time and Gs activation response 20 min after agonist washout. Gs activity was determined by assessing the reduction in BRET signal between RlucII-117-Gas and GFP10-Gg1. Surface expression of all GPCRs was matched. Data are shown as a percent of BRET decrease observed in the unwashed condition (i.e., in the continuous presence of agonist) and represents the mean ± SE of N = 4-5 experiments. Oneway ANOVA was performed to assess significant differences in Gs response by increasing agonist stimulation time versus pulse stimulation (0.5 min) (*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001). See also Figure S1 .
the cytoplasm, and after 5 min of receptor stimulation mEmerald-67-Gas was predominantly distributed within the cytoplasm ( Figures 3A, S2 , and S3A). In contrast, following agonist stimulation, mStrawberry-barr2 was recruited from the cytoplasm to the activated SNAP-tagged receptors (5 min post-stimulation) at the plasma membrane followed by GPCRbarr complex internalization into endosomes (>20 min post-stimulation) ( Figures 3A, S2 , and S3A). At longer agonist exposure times (>20 min post-stimulation), increased mEmerald-67-Gas intensity can be visualized in b 2 V 2 R-barr2 and V 2 R-barr2 containing endosomes (Figures 3 and S3 ), but this was not observed for the b 2 AR, which is likely because it only forms transient complexes with barr2 ( Figure S2 ). Line-scan analysis of all three fluorophores within these endosomes demonstrates co-localization of b 2 V 2 R/V 2 R, barr2, and Gas, supporting the hypothesis that ''megaplexes'' of class B GPCRs, barr, and heterotrimeric Gs form in endosomes ( Figures 3B, 3C , S2B, and S3C).
Agonist-Stimulated Interaction between barrs and Gs Subunits
To confirm close molecular proximity between different megaplex components following receptor stimulation, we utilized BRET. If megaplexes form, G protein and barr will simultaneously interact with a single active receptor, and thus, measurement of BRET between functionally validated Gs subunits (Gas or Gg2) A B C and barr1/2 following agonist stimulation can serve to detect these complexes ( Figures 4A and S1 ). In BRET titration experiments, agonist-stimulation for 20 min of either b 2 V 2 R or V 2 R increased the BRET signal between RlucII-67-Gas and GFP10-barr1/2 ( Figures 4B and 4D) . A significant agonist-promoted BRET increase between RlucII-Gg2 and GFP10-barr1/2 was also detected, indicating that the agonist-promoted recruitment of barr1/2 to the b 2 V 2 R or V 2 R brings barr1/2 into close proximity to both the Gas and Gbg subunits. In contrast, no change in the BRET signal was detected between GFP10-barr1/2 and either RlucII-67-Gas or RlucII-Gg2 following ISO treatment of b 2 AR-transfected HEK293 cells ( Figures 4B and  4D ). Interestingly, in BRET kinetic experiments, which are slightly more sensitive than titration experiments, a weak ISO-promoted BRET signal was observed between GFP10-barr1/2 and RlucII-67-Gas but not RlucII-Gg2 in cells expressing b 2 AR. ( Figures  4C and 4E) . In BRET kinetic experiments, for both b 2 V 2 R and V 2 R, the agonist-mediated signals between barr1/2 and both RlucII-67-Gas and RlucII-Gg2 were pronounced and rapidly increased until plateauing $10 min after agonist treatment.
In the resting state heterotrimeric Gs is initially located at the cell membrane and barr is dispersed within the cytoplasm, thus, we tested whether the BRET signals detected following agonist stimulation could have arisen from random collisions between the plasma membrane-translocated barr and any membrane proteins. To control for this possibility, BRET was measured between the membrane protein RlucII-CD8 and GFP10-barr1/2 following agonist-stimulation of b 2 AR, b 2 V 2 R or V 2 R ( Figure 4A ). In this setup, no BRET response was observed following agonist stimulation of any of the receptors indicating that the BRET detected between barr and both Gas and Gg2 reflects molecular proximity consistent with the formation of megaplexes ( Figures 4B-4E ). Taken together, these experiments provide further evidence that megaplexes containing receptor, barr and Gs form robustly at both the b 2 V 2 R and V 2 R. (legend continued on next page)
GPCR-barr Fusion Proteins Activate Heterotrimeric G Protein following Agonist Stimulation
The BRET and confocal data shown thus far support the existence of megaplexes and suggest that these complexes occur more readily for the class B GPCRs, b 2 V 2 R and V 2 R, and minimally for the class A b 2 AR. However, these results do not demonstrate whether GPCR-barr complexes can directly activate G protein. To investigate whether GPCR-barr complexes can interact with, and activate, G protein in a cellular environment we generated fusion proteins of GPCR-barr and investigated their ability to activate Gs in HEK293 cells. We used the b 2 V 2 R as our model class B GPCR to be consistent with the biophysical experiments in this study where we assessed the ability of a purified b 2 V 2 R-barr1 complex to interact with, and activate, Gs (see below). To date, we have been unable to purify biochemically functional GPCR-barr complexes using other class B GPCRs, such as the V 2 R. The b 2 V 2 R has been rigorously characterized both herein and in previous studies; it displays similar biological properties to the V 2 R, as well as to other class B (C and E) Kinetics of agonist-promoted BRET between GFP10-barr1 (C) or GFP10-barr2 (E) and RlucII-Gas, RlucII-Gg2, or RlucII-CD8 obtained for all three GPCRs. Each kinetic point represents the mean ± SE of DBRET between agonist-stimulated and vehicle-treated conditions (N = 3-10 experiments). Two-way ANOVA was performed to determine significant differences between CD8 condition and Gas or Gg2 for each time point ( a p < 0.05; b p < 0.01; c p < 0.001; d p < 0.0001).
See also Figures S1 and S5 . GPCRs, and has been routinely used as a robust model class B GPCR (Lee et al., 2016; Oakley et al., 1999 Oakley et al., , 2000 Tohgo et al., 2003 ). Initially, we tested the functionality and stability of the b 2 V 2 Rbarr1/2 fusions. Immunoprecipitation (IP) of the FLAG-tagged fusion proteins, expressed in HEK293 cells, confirmed that the fusions were intact and not subjected to cellular cleavage (Figures S4A and S4B ). When compared with b 2 V 2 R, ISO-promoted displacement of 125 I-cyanopidolol (CYP) binding for both b 2 V 2 Rbarr1/2 fusions revealed a biphasic curve reflecting a higher affinity state for agonist ( Figure 5A ): b 2 V 2 R-barr1 dissociation constant logKi Hi = À7.11 ± 0.03 (41%) and logKi Lo = 6.01 ± 0.03 (59%); and b 2 V 2 R-barr2 dissociation constant logKi Hi = À8.29 ± 0.03 (49%) and logKi Lo = À6.47 ± 0.03 (51%). These results are characteristic of the allosteric effect of barr on receptor binding properties, as previously reported (Gurevich et al., 1997) , and confirm the functional interaction between the two moieties of the fusions. Fusion to barr had no effect on the affinity of the antagonist ICI-118551 ( Figure 5A ). When expressed in HEK293 cells both fusions constitutively internalize resulting in a relatively low amount of b 2 V 2 R-barr1/2 fusions being present at the cell membrane ( Figure 5B ). This internalization pattern further shows that barr, as a fusion partner, retains its functionality to promote barr-mediated receptor endocytosis. Furthermore, when stimulated with ISO, the b 2 V 2 R-barr1/2 fusions promote ERK1/2 phosphorylation at 10 min post-stimulation ( Figures 5C and S4C ). These results indicate that both individual proteins, of the b 2 V 2 R-barr1/2 fusions, are functional when expressed in cells. To test whether b 2 V 2 R, as part of the b 2 V 2 R-barr fusions, retains its ability to activate Gs, changes in BRET were measured between RlucII-117-Gas and GFP10-Gg1 in response to ISO stimulation as compared to vehicle treatment. As shown in Figure 5D , ISO stimulation of b 2 V 2 R-barr1/2 induced a decreased BRET between RlucII-117-Gas and GFP10-Gg1, reflective of the Gs subunits separation and activation, although to a lesser extent than non-fused b 2 V 2 R. These results demonstrate that both b 2 V 2 R-barr1/2 fusions can activate Gs to some degree, following agonist-mediated receptor stimulation, despite their constant coupling to functional barr1/2.
To further confirm the ability of the b 2 V 2 R-barr1/2 fusions to activate Gs, real-time kinetic studies of ISO-stimulated cAMP production were undertaken. Both b 2 V 2 R-barr1/2 fusions were able to initiate Gs signaling ( Figure 5E ), providing further support that G proteins are capable of being activated by GPCR-barr complexes.
In Vitro Formation and Isolation of Megaplexes
To further investigate whether GPCRs can form megaplexes by simultaneously interacting with barr and heterotrimeric G protein, we attempted to form such megaplexes in vitro and to then isolate them by co-immunoprecipitation (coIP). For this study, we used the FLAG-b 2 V 2 R expression construct to form stable complexes with barr1 in sf9 insect cells, as previously described (Shukla et al., 2014) . Following stimulation with the high-affinity agonist, BI-167107 (BI), b 2 V 2 R forms appreciable amounts of complex with barr1 that can be purified by affinity purification and size-exclusion chromatography (SEC). To obtain highly stable b 2 V 2 R-barr1 complexes, that remain intact throughout the purification, we added the conformationally active antibody binder, Fab30, which binds to and stabilizes active barr1 conformations (Shukla et al., 2013 (Shukla et al., , 2014 . We were unable to obtain monodispersed and functional V 2 Rbarr1 complexes using this approach (data not shown).
To test whether this Fab30-stabilized BI-occupied b 2 V 2 Rbarr1 complex (Fab30 complex) interacts with the heterotrimeric Gs, we added purified Gs in excess to the Fab30 complex and pulled-down the FLAG-b 2 V 2 R using M1 anti-FLAG beads. As shown in Figure 6A , barr1 and all three components of the heterotrimeric Gs (Gas, Gb1, and Gg2) were pulleddown together with FLAG-b 2 V 2 R in a stoichiometric fashion. A similar result was observed when using protein A/G agarose beads, which bind Fab30, to pull-down the individual components of the megaplex, confirming that it forms in vitro ( Figure 6A ).
Megaplex In Vitro Functionality
To test the functionality of the receptor in the megaplex we first investigated whether binding of the heterotrimeric Gs to the Fab30 complex is agonist-dependent by FLAG-tag coIP (Figure 6C ). The Fab30 complex was able to bind Gs to a similar extent as agonist BI-bound b 2 V 2 R ( Figures 6C and S5A ). In contrast, the antagonist carazolol (Cz)-bound b 2 V 2 R had almost no ability to bind Gs indicating that the binding of the heterotrimeric Gs to b 2 V 2 R in the Fab30 complex is dependent on an agonist-stabilized active receptor conformation ( Figures 6C  and S5A ).
We next investigated whether the b 2 V 2 R maintains its guanine nucleotide exchange factor (GEF) functionality with respect to the heterotrimeric Gs when residing in the megaplex. To assess GEF functionality, the megaplex was formed in the presence of either GDP or non-hydrolysable GTPgS. An exchange of GDP to GTPgS in the heterotrimeric Gs causes activation of the Gas subunit and separation from the Gbg subunits ( Figure 6B ). This separation event was followed by a FLAG-tag coIP. The addition of GDP caused a small decrease in Gs binding to the BI-occupied b 2 V 2 R and Fab30 complex ( Figures 6D and S5B) . However, the addition of GTPgS led to a nearly complete separation of the Gas subunit from both the BI-occupied b 2 V 2 R and Fab30 complex ( Figures 6D and S5B ). This dramatic effect indicates that the receptor retains its GEF functionality while residing in the megaplex and can promote G protein activation and separation. Interestingly, unlike the Gas subunit, the Gbg subunits remained in complex with both the Fab30 complex and BI-occupied b 2 V 2 R after GTPgS treatment ( Figure S5B ). (B) Schematic presentation of the biochemical steps in G protein activation in the megaplex: (1) heterotrimeric G protein is recruited to the GPCR-barr ''tail'' conformation to form the megaplex in an agonist-dependent manner; (2) activated receptor in the megaplex stimulates GDP-GTP exchange in the heterotrimeric G protein, causing activation and separation of the Gas subunit; and (3) activated Gas subunit has intrinsic GTPase activity causing hydrolysis of GTP to GDP and inorganic phosphate (Pi). (C) M1 anti-FLAG coIP experiment of BI-occupied b 2 V 2 R, Fab30 complex, or Cz-occupied b 2 V 2 R both with and without heterotrimeric Gs present. Gs binding was determined and quantified by western blot using an anti-Gas antibody. Data represent the mean ± SE of N = 4 experiments. One-way ANOVA was performed with pairwise comparison to BI-b 2 V 2 R (****p < 0.0001). (D) M1 anti-FLAG coIP experiment with either BI-occupied b 2 V 2 R-Gs complex or megaplex in presence of control buffer, 20 mM GDP, or 20 mM GTPgS. Gas subunit separation was determined and quantified by western blot by using an anti-Gas antibody. Data represent the mean ± SE of N = 4 experiments. Two-way ANOVA was performed to assess significant differences between control buffer (*p < 0.05; **p < 0.01; ****p < 0.0001) and GDP (####, p < 0.0001). There were no statistical differences between the BI-occupied b 2 V 2 R-Gs complex and the megaplex. (E) Characterizing the ability of BI-occupied b 2 V 2 R (top) or Fab30 complex (bottom) to modulate GDP-GTP exchange and Gs activity via GTPase activity. Data represent the mean ± SE of N = 5-6 experiments. Two-way ANOVA was performed to test the effect of Gs presence at each receptor/complex concentrations (**p < 0.01; ****p < 0.0001), and one-way ANOVA tests the effect on Gs modulation by different receptor/complex concentrations (#, p < 0.05; ####, p < 0.0001). See also Figure S5 .
Once activated by the receptor, the Gas subunits display intrinsic GTPase activity. To further characterize the b 2 V 2 R functionality in the megaplex, modulation of Gs, measured as GTPase activity by the Fab30 complex, was investigated. As shown in Figure 6E , the Fab30 complex does indeed positively modulate the GTPase activity of the Gs, and to a similar level as the BI-occupied b 2 V 2 R control.
These in vitro experiments clearly show that the receptor, in the megaplex, retains its full capability to both interact with and to activate heterotrimeric Gs.
Structural Studies of the Megaplex Using Electron Microscopy
To investigate the architecture of the megaplex, we formed complexes on a preparative scale and isolated them by SEC ( Figures  S6A and S6B) . To increase the overall stability and homogeneity of the megaplex preparation, we employed two strategies, which were previously utilized to form stable b 2 AR-Gs complexes (Rasmussen et al., 2011): (1) Gs by addition of apyrase; and (2) we stabilized the nucleotide-free transition state of the Gs, which is known to interact strongly with the b 2 AR transmembrane core region by adding the conformationally active nanobody binder, Nb35. These two strategies resulted in a stable and monodisperse preparation of megaplexes as assessed by SEC and conventional negative-stain EM (Figures 7 and S6 ) (Peisley and Skiniotis, 2015) . The b 2 V 2 R construct used for our in vitro studies was engineered to contain an N-terminal T4-lysozyme fusion, (T4L) b 2 V 2 R, which can be used as a marker for receptor orientation in EM studies (Shukla et al., 2014; Westfield et al., 2011) .
To visualize the structure of the in vitro reconstituted megaplex we applied classification and averaging of the EM particle projections ( Figure S6C ). The class averages revealed a complex architecture with distinct features that allow domain assignment, with the T4L marking the receptor extracellular face and the heterotrimeric Gs bound diametrically opposite at the intracellular side of b 2 V 2 R, in a configuration that appears identical to the previously characterized (T4L) b 2 AR-Gs ( Figures 7B and 7C) (Westfield et al., 2011) . Additional density attributed to barr1-Fab30 is observed on the side of the b 2 V 2 R-Gs complex. This configuration of barr1, which interacts with the phosphorylated b 2 V 2 R C-terminal tail, is reminiscent of the 'tail' conformation of the (T4L)b 2 V 2 R-barr1-Fab30 complex that we previously reported by EM (Shukla et al., 2014) . In fact, overlaying the averages of the (T4L)b 2 AR-Gs complex and the 'tail' configuration of the (T4L)b 2 V 2 R-barr1-Fab30 complex (using receptor and T4L densities as the common features) results in a projection that appears almost identical to the one of the megaplex ( Figures 7B and 7C ). In this super-complex, barr1 is positioned adjacent to the Gbg subunits and several class averages indicate a direct interface between Gbg and barr1 (Figure S6C ). This possible Gbg-barr1 interaction was further explored by glutathione sepharose (GST) pull-down assays, whereby an interaction between the GST-barr1, in complex with Fab30 and the phosphorylated V 2 R C-terminal peptide (V 2 Rpp), and heterotrimeric Gs was observed ( Figure S7 ). Interestingly, when the Gbg subunits were separated from the Gas subunit by addition of non-hydrolysable GTP surrogate, GDP,AlF 4 À , Gbg binds GST-barr1 more prominently whereas Gas subunit association with GST-barr1 diminishes ( Figures  S7B and S7C) . These results suggest that a direct interaction occurs between barr1 and Gbg subunits. Consistent with this finding, we further demonstrated that expression of the Gbg scavenger, T8-bARKct, significantly reduced the b 2 V 2 R-stimulated BRET response between RlucII-Gg2 and GFP10-barr1 in HEK293 cells ( Figure S7D ).
DISCUSSION
Sustained G protein signaling by internalized GPCRs has been difficult to incorporate within the classical understanding of GPCR signaling since receptor internalization is thought to be driven by the formation of GPCR-barr complexes and because barr plays a fundamental role in the desensitization of GPCRmediated G protein signaling. Thus, we found it surprising that class B GPCRs, including PTHR, V 2 R, and TSHR, which are known to interact tightly with barr, have been shown to promote sustained G protein signaling from internalized compartments (Calebiro et al., 2009; Feinstein et al., 2013; Ferrandon et al., 2009; Wehbi et al., 2013) . In the current study we directly demonstrate that by exchanging the C-terminal tail of the b 2 AR with the V 2 R C-terminal tail (b 2 V 2 R), the receptor internalization pattern changes from class A to B and that the b 2 V 2 R chimera displays behavior similar to the V 2 R (Figures 3A and S2) (Oakley et al., , 2000 . Interestingly, as observed with the V 2 R, this modification significantly enhances the ability of the b 2 V 2 R, relative to b 2 AR, to promote sustained G protein activation and signaling from internalized compartments (Figures 1 and 2) . Previous findings suggest a role for barr in sustained G protein signaling by the PTHR and V 2 R. Co-expression of a constitutively active version of barr1 enhances sustained G protein signaling at the PTHR and V 2 R, and such signaling was diminished by small interfering RNA (siRNA) knockdown of both barr1/2 (Feinstein et al., 2011 Wehbi et al., 2013) . In contrast, for the class A GPCR, b 2 AR, desensitization of Gs signaling is enhanced by a constitutively active barr1, but diminished by siRNA knockdown of barr1/2 (Violin et al., 2008; Wehbi et al., 2013) .
How is barr involved in receptor-mediated G protein activation at internalized GPCRs? Several studies with the PTHR, V 2 R, TSHR, d opioid, and CCR1 (Audet et al., 2012; Calebiro et al., 2009; Feinstein et al., 2013; Ferrandon et al., 2009; Gilliland et al., 2013; Wehbi et al., 2013) indirectly support our megaplex hypothesis for GPCRs. In the present study, however, we provide direct evidence for formation of megaplexes; super-complexes in which the heterotrimeric Gs subunits come into close proximity with barr1/2 following stimulation of the b 2 V 2 R or V 2 R (Figure 4 ). This event seems to occur at internalized receptors (Figure 3) . Furthermore, following agonist addition, b 2 V 2 Rbarr1/2 fusions retain the ability to activate Gs and promote signaling (Figures 5 and S4 ). We demonstrated in vitro that the receptor in a purified agonist-occupied b 2 V 2 R-barr1-Fab30 complex interacts strongly with heterotrimeric Gs through its transmembrane core, while it couples simultaneously with barr1 through the receptor C-terminal tail (Figures 6 and 7) . This megaplex architecture allows the receptor to promote GDP-GTP exchange and to activate Gs (Figures 6, S5 , and S6) and thus explains how barr can drive receptor internalization without interfering with G protein coupling to the receptor.
Why does barr partake in sustained internalized G protein activation at class B GPCRs, while desensitizing it at others, such as the prototypical class A GPCR, b 2 AR? The current study suggests that a strong interaction between the GPCR C-terminal tail and barr is required to robustly form a megaplex (Figures 4, 6 , and 7). To obtain a highly stable b 2 V 2 R-barr1 complex, used for the aforementioned structural studies, this complex was engineered to have a strong interaction between the receptor C-terminal tail and barr1, which was accomplished by exchanging the b 2 AR C-terminal tail with the V 2 R C-terminal tail and stabilizing the active conformation of barr1 with Fab30 (Shukla et al., 2014) . b 2 V 2 R and barr1 only interact through the V 2 R C-terminal tail region in the ''tail'' conformation, which is the arrangement that allows the receptor to interact with Gs. Thus, in order to form megaplexes, it might be a requirement for GPCRs to have a C-terminal tail that promotes a strong interaction with barr following phosphorylation. Class B GPCRs have been reported to contain highly conserved serine/threonine phosphorylation site clusters in their C-terminal tails, which are critical for the formation of highly stable GPCR-barr complexes (Oakley et al., 2001; Vilardaga et al., 2002) . Therefore, a dependency on a strong C-terminal tail interaction, that promotes the ''tail'' conformation, could explain why class B GPCRs form megaplexes that lead to G protein signaling from internalized compartments. On the other hand, class A GPCRs lack serine/threonine clusters at their C-terminal tails and, thus, promote a transient interaction between the GPCR C-terminal tail and barr (Oakley et al., 2001) . Therefore, formation of class A GPCR-barr complexes, might be dependent on the interaction between the receptor transmembrane core and barr, which would explain why class A GPCRs only form megaplexes to a limited degree.
Overall, our results indicate that megaplexes of a single class B GPCR, barr, and heterotrimeric G protein exist and may explain the recently appreciated phenomenon of sustained G protein signaling from endosomes.
EXPERIMENTAL PROCEDURES
Real-Time Measurement of cAMP Production HEK293-ICUE2 cell lines transiently transfected with GPCRs were imaged in the dark, on a 37 C temperature-controlled stage, and for the entire stimulation experiment by using a DeltaVision Deconvolution microscope (GE Healthcare) with a Coolsnap HQ2 CCD camera (Photometrics) controlled by SoftWoRx 6.1 (GE Healthcare). Dual-emission ratio imaging used a CFP/YFP dichroic mirror and 470 ± 24 nm and 535 ± 25 nm emission filters for CFP and YFP, respectively.
BRET Assay
Following agonist stimulation, transfected HEK293 cells were incubated at 37 C and luciferase substrate coelenterazine 400a was added 5 min prior to reading BRET in a Synergy Neo microplate reader (BioTek) equipped with an acceptor filter (515 ± 30 nm) and donor filter (410 ± 80 nm). The BRET signal was determined as the ratio of light emitted by GFP10-tagged biosensors (energy acceptors) and light emitted by RlucII-tagged biosensors (energy donors).
Confocal Microscopy HEK293 cells transfected with fluorescence protein were fixed with ice-cold 6% formaldehyde diluted in DPBS prior to, or at different time points, during stimulation of the GPCRs. Confocal images were obtained on a Zeiss LSM510 laser-scanning microscope using multi-track sequential excitation (488, 568, and 633 nm) and emission (515-540, 585-615, and 650 nm) filter sets.
Co-immunoprecipitation of In Vitro Complexes
Fab30 complex, BI-b 2 V 2 R, or Cz-b 2 V 2 R were mixed with Gs in a molar ratio of 1:1.5 in presence of control buffer, 100 nM BI, 100 nM Cz, 20 mM GDP, or 20 mM GTPgS. Next, FLAG-b 2 V 2 R was immobilized on M1 anti-FLAG agarose beads followed by extensive wash. Finally, FLAG-b 2 V 2 R and associated proteins were eluted by elution buffer containing 1 mg/ml FLAG peptide.
Megaplex Preparation for Structural Studies
To form stable megaplexes, Fab30 complex was incubated with Gs and Nb35 in a molar ratio of 1:1.5:3 for 1 hr at room temperature. Megaplex was treated with 25 mU/ml of apyrase for 1 hr, and the CaCl 2 concentration was adjusted to 4 mM. Finally, the megaplex was purified on an SEC column (Superdex 200, 16/600, GE Healthcare).
Electron Microscopy
Megaplexes were prepared for EM using conventional uranyl formate negative staining. The negative-stained sample was imaged at room temperature with a Tecnai T12 electron microscope operated at 120 kV using lowdose procedures. Images were recorded at a magnification of 71,1383 and a defocus value of $1.5 mm on a Gatan US4000 CCD camera. All images were binned (2 3 2 pixels) to obtain a pixel size of 4.16 Å on the specimen level. 
